AVLAR BIOVENTURES
Avlar was founded in 1999 by Alan Goodman and Daniel Roach and manages Avlar Fund II (£43m) and the First Cambridge Gateway Fund (£35m). Avlar has invested in eighteen companies across a range of sub-sectors of the bioscience industries. Ten are still private, two have been merged, three have been bought by public companies, two have been sold for cash and two listed on the public markets. Prior to the formation of Avlar Messrs Roach and Goodman co-founded or seed financed nine life science companies. Seven of these were listed on recognized Stock Exchanges producing highly profitable realizations. These included Acambis, Chiroscience, Core, Salix and Oxford Biomedica.
AVLAR BIOVENTURES
Industry:
Finance Financial Services Venture Capital
Founded:
1999-01-01
Status:
Closed
Contact:
44 (0) 1954 211 515
Email Addresses:
[email protected]
Technology used in webpage:
Common Name Invalid British Server Location Zen Internet
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2010-01-20 | Crescendo Biologics | Avlar BioVentures investment in Series A - Crescendo Biologics | 7.3 M USD |
| 2009-10-12 | Crescendo Biologics | Avlar BioVentures investment in Seed Round - Crescendo Biologics | 4.5 M GBP |
| 2006-07-18 | CellCentric | Avlar BioVentures investment in Venture Round - CellCentric | 1.2 M GBP |
| 2006-07-07 | Takeda Cambridge | Avlar BioVentures investment in Series D - Takeda Cambridge | 12.96 M USD |
| 2006-01-01 | NXVISION | Avlar BioVentures investment in Venture Round - NXVISION | 688 K USD |
| 2005-08-01 | Intercytex Group | Avlar BioVentures investment in Series D - Intercytex Group | 12 M GBP |
| 2005-05-01 | Amura | Avlar BioVentures investment in Venture Round - Amura | 1.84 M USD |
| 2005-04-07 | CellCentric | Avlar BioVentures investment in Venture Round - CellCentric | 250 K GBP |
| 2005-01-07 | Takeda Cambridge | Avlar BioVentures investment in Venture Round - Takeda Cambridge | 9.38 M USD |
| 2004-12-01 | Purely Proteins Limited | Avlar BioVentures investment in Series B - Purely Proteins Limited | 3.6 M USD |
More informations about "Avlar BioVentures"
Avlar BioVentures - Crunchbase Investor Profile
Avlar was founded in 1999 by Alan Goodman and Daniel Roach and manages Avlar Fund II (£43m) and the First Cambridge Gateway Fund (£35m). Avlar has invested in eighteen companies across a range of sub-sectors of the …See details»
Avlar BioVentures
Avlar BioVentures is a private equity firm based in Cambridge, United Kingdom, founded in 1998 by Alan Goodman and Daniel Roach. The firm specializes in early-stage investments within …See details»
Avlar Ltd - Company Profile and News - Bloomberg Markets
Company profile page for Avlar Ltd including stock price, company news, executives, board members, and contact information. ... Avlar Bioventures serves clients in the United Kingdom. ...See details»
Avlar BioVentures - Funding, Financials, Valuation & Investors
Avlar BioVentures has raised 2 funds, their latest being AVLAR BIOVENTURES FUND II. Funds Raised. Edit Funds Raised Section. Number of Funds 2. Avlar BioVentures has raised 2 funds, …See details»
AVLAR LIMITED overview - Find and update company information
More for AVLAR LIMITED (03538767) Registered office address Highfield Court Church Lane, Madingley, Cambridge, United Kingdom, CB23 8AG . Company status Active ... AVLAR …See details»
Avlar BioVentures investment portfolio - PitchBook
Avlar BioVentures's latest investment was on 05-Oct-2012 in Crescendo Biologics, a company within the Drug Discovery industry. Data Transparency. Meet our data hygiene team. Discover …See details»
Avlar BioVentures - CB Insights
Jan 2, 2000 Avlar is a biotechnology venture capital company which currently has over Euro150 million under management in Avlar BioVentures Fund I, Avlar BioVentures Fund II and the …See details»
Avlar BioVentures - Investments, Portfolio & Company Exits
Avlar BioVentures has had . obfuscated. obfuscated. exit, which was NXVISION. Which industries has this organization had the most exits in? Show . NXVISION NXVISION is a web platform …See details»
Avlar Bioventures - Investor Profile, Portfolio & Team - Tracxn
Avlar Bioventures - VC firm focused on early stage investments in bioscience industry. Portfolio of 8 companies. 14 investors have invested with Avlar Bioventures. Team has 2 partners.See details»
AVLAR BIOVENTURES FUND I LIMITED PARTNERSHIP
Company Overview for AVLAR BIOVENTURES FUND I LIMITED PARTNERSHIP (LP006059) Filing history for AVLAR BIOVENTURES FUND I LIMITED PARTNERSHIP (LP006059) More …See details»
Avlar BioVentures – Investors Database - Unicorn Nest
Avlar BioVentures is the famous VC, which was founded in 1999. The company was established in Europe in United Kingdom. The leading representative office of defined VC is situated in the …See details»
Avlar BioVentures Ltd. - BioCentury Company Profiles - BCIQ
Avlar BioVentures Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
Alan Goodman - Owner - Avlar Bioventures | LinkedIn
Owner, Avlar Bioventures · Experience: Avlar Bioventures · Location: Greater Cambridge Area · 500+ connections on LinkedIn. View Alan Goodman’s profile on LinkedIn, a professional …See details»
Avlar BioVentures | Institution Profile | Private Equity International
Avlar BioVentures. News, insights, analysis and data. Avlar BioVentures overview. Incorporated in 1998, Avlar BioVentures was a Cambridge-based private equity firm, targeting early-stage …See details»
Avlar BioVentures
Avlar BioVentures Avlar was founded in 1999 by Alan Goodman and Daniel Roach and manages Avlar Fund II (£43m) and the First Cambridge Gateway Fund (£35m). Avlar has invested in …See details»
Avlar acquires fellow Cambridge fund manager Gateway Global …
2 days ago Acquisition Avlar BioVentures Ltd, of Cambridge, a specialist early-stage venture capital company, is acquiring Gateway Global Partners Ltd, manager of the Cambridge …See details»
Avlar BioVentures | Unquote
Sep 5, 2023 Avlar BioVentures has announced the following internal changes: Daniel Roach, previously non-executive director, has become executive director; Alan Goodman, …See details»
Avlar BioVentures - Tech Stack, Apps, Patents & Trademarks
Jul 15, 2024 Avlar BioVentures is actively using 10 technologies for its website, according to BuiltWith. These include SPF, DMARC, and Microsoft Exchange Online. UNLOCK PREMIUM …See details»
AVLAR BIOVENTURES SCOTTISH GP LIMITED - Companies House
May 15, 2015 More for AVLAR BIOVENTURES SCOTTISH GP LIMITED (SC216285) Registered office address 50 Lothian Road, Festival Square, Edinburgh, Midlothian, EH3 9BY …See details»
Q&A with BioVentures’ Stefanie Kennon-McGill
Q: BioVentures plays a crucial role in commercializing university research. What are some key challenges researchers face in turning discoveries into startups? A: I think the biggest …See details»